{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:41:56Z","timestamp":1790959316536,"version":"4.1.0"},"reference-count":274,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["AG042178"],"award-info":[{"award-number":["AG042178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["AG047812"],"award-info":[{"award-number":["AG047812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["NS105473"],"award-info":[{"award-number":["NS105473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["AG060767"],"award-info":[{"award-number":["AG060767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["AG069333"],"award-info":[{"award-number":["AG069333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["AG066347"],"award-info":[{"award-number":["AG066347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12035-021-02556-x","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T04:02:26Z","timestamp":1631592146000},"page":"6350-6377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Mitochondrial Abnormalities and Synaptic Damage in Huntington\u2019s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics"],"prefix":"10.1007","volume":"58","author":[{"given":"Neha","family":"Sawant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arubala P.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-9948","authenticated-orcid":false,"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"2556_CR1","unstructured":"Huntington G (1872) On Chorea, Medical and Surgical Reporter."},{"issue":"1","key":"2556_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0972-2327.175425","volume":"19","author":"KB Bhattacharyya","year":"2016","unstructured":"Bhattacharyya KB (2016) The story of George Huntington and his disease. Ann Indian Acad Neurol 19(1):25\u201328","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"2556_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrg1686","volume":"6","author":"GP Bates","year":"2005","unstructured":"Bates GP (2005) History of genetic disease: the molecular genetics of Huntington disease - a history. Nat Rev Genet 6(10):766\u2013773","journal-title":"Nat Rev Genet"},{"key":"2556_CR4","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA et al. (2015) Huntington disease. Nat Rev Dis Primers 1:15005","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2556_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1212\/01.WNL.0000129827.16522.78","volume":"63","author":"MS Okun","year":"2004","unstructured":"Okun MS, Thommi N (2004) Americo Negrette (1924 to 2003): diagnosing Huntington disease in Venezuela. Neurology. 63(2):340\u2013343","journal-title":"Neurology."},{"issue":"4","key":"2556_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1590\/S0004-282X2011000500025","volume":"69","author":"M Moscovich","year":"2011","unstructured":"Moscovich M, Munhoz RP, Becker N, Barbosa BR, Espay AJ, Weiser R, Teive HA (2011) Am\u00e9rico Negrette and Huntington\u2019s disease. Arq Neuropsiquiatr 69(4):711\u2013713","journal-title":"Arq Neuropsiquiatr"},{"issue":"6109","key":"2556_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/326194a0","volume":"326","author":"NS Wexler","year":"1987","unstructured":"Wexler NS, Young AB, Tanzi RE, Travers H, Starosta-Rubinstein S, Penney JB, Snodgrass SR, Shoulson I et al. (1987) Homozygotes for Huntington\u2019s disease. Nature. 326(6109):194\u2013197","journal-title":"Nature."},{"key":"2556_CR8","doi-asserted-by":"crossref","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G et al. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci USA 101(10):3498\u20133503","DOI":"10.1073\/pnas.0308679101"},{"issue":"8","key":"2556_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1474-4422(13)70170-4","volume":"12","author":"NS Wexler","year":"2013","unstructured":"Wexler NS (2013) Three decades of caring for the Venezuelan Huntington\u2019s disease families. Lancet Neurol 12(8):738","journal-title":"Lancet Neurol"},{"issue":"5940","key":"2556_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K et al. (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306(5940):234\u2013238","journal-title":"Nature"},{"key":"2556_CR11","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"11","key":"2556_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.050930","volume":"44","author":"VC Wheeler","year":"2007","unstructured":"Wheeler VC, Persichetti F, McNeil SM, Mysore JS, Mysore SS, MacDonald ME, Myers RH, Gusella JF et al. (2007) US-Venezuela Collaborative Research Group, Factors associated with HD CAG repeat instability in Huntington disease. J Med Genet 44(11):695\u2013701","journal-title":"J Med Genet"},{"issue":"1","key":"2556_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"issue":"2","key":"2556_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archneur.58.2.273","volume":"58","author":"SC Kirkwood","year":"2001","unstructured":"Kirkwood SC, Su JL, Conneally P, Foroud T (2001) Progression of symptoms in the early and middle stages of Huntington disease. Arch Neurol 58(2):273\u2013278","journal-title":"Arch Neurol"},{"issue":"1","key":"2556_CR15","first-page":"21","volume":"31","author":"A Montoya","year":"2006","unstructured":"Montoya A, Price BH, Menear M, Lepage M (2006) Brain imaging and cognitive dysfunctions in Huntington\u2019s disease. J Psychiatry Neurosci 31(1):21\u201329","journal-title":"J Psychiatry Neurosci"},{"key":"2556_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398","journal-title":"Lancet Neurol"},{"key":"2556_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","volume":"8","author":"P Pla","year":"2014","unstructured":"Pla P, Orvoen S, Saudou F, David DJ, Humbert S (2014) Mood disorders in Huntington\u2019s disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci 8:135","journal-title":"Front Behav Neurosci"},{"issue":"6","key":"2556_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44(6):559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"issue":"23","key":"2556_CR19","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L et al. (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21(23):9112\u20139123","journal-title":"J Neurosci"},{"issue":"9","key":"2556_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27(9):1083\u20131091","journal-title":"Mov Disord"},{"issue":"2","key":"2556_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"PH Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO Jr, Miller G, Tagle DA (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20(2):198\u2013202","journal-title":"Nat Genet"},{"issue":"20","key":"2556_CR22","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19(20):3919\u20133935","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2556_CR23","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A, Strand A, Torcassi C et al. (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 3(5):e82","journal-title":"PLoS Genet"},{"issue":"5","key":"2556_CR24","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of Huntingtin. Neuron 89(5):910\u201326","journal-title":"Neuron"},{"issue":"2","key":"2556_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum Mol Genet 21(2):406\u2013420","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2556_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"PH Reddy","year":"2009","unstructured":"Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Res Rev 61(1):33\u201348","journal-title":"Brain Res Rev"},{"key":"2556_CR27","first-page":"101","volume":"2","author":"PH Reddy","year":"1822","unstructured":"Reddy PH (1822) Shirendeb UP (2012) Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington\u2019s disease. Biochim Biophys Acta 2:101\u2013110","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"2556_CR28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20(7):438\u20131455","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2556_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1326-6-32","volume":"6","author":"E Taherzadeh-Fard","year":"2011","unstructured":"Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L (2011) PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 6(1):32","journal-title":"Mol Neurodegener"},{"issue":"18","key":"2556_CR30","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V et al. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24(18):8195\u20138209","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2556_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jnc.14723","volume":"150","author":"AI Smith-Dijak","year":"2019","unstructured":"Smith-Dijak AI, Sepers MD, Raymond LA (2019) Alterations in synaptic function and plasticity in Huntington disease. J Neurochem 150(4):346\u2013365","journal-title":"J Neurochem"},{"issue":"1","key":"2556_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berr\u00edos L, Rosario N, Dufault V, Skatchkov S, Eaton MJ, Torres-Ramos CA, Ayala-Torres S (2009) Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair (Amst.) 8(1):126\u2013136","journal-title":"DNA Repair (Amst.)"},{"issue":"2","key":"2556_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI45691","volume":"121","author":"F Mochel","year":"2011","unstructured":"Mochel F, Haller RG (2011) Energy deficit in Huntington disease: why it matters. J Clin Invest 121(2):493\u2013499","journal-title":"J Clin Invest"},{"issue":"10","key":"2556_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11(10):682\u2013696","journal-title":"Nat Rev Neurosci"},{"key":"2556_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.lfs.2018.07.030","volume":"209","author":"MM Golas","year":"2018","unstructured":"Golas MM (2018) Human cellular models of medium spiny neuron development and Huntington disease. Life Sci 209:179\u2013196","journal-title":"Life Sci"},{"issue":"43","key":"2556_CR36","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1073\/pnas.0808488105","volume":"105","author":"L Aubry","year":"2008","unstructured":"Aubry L, Bugi A, Lefort N, Rousseau F, Peschanski M, Perrier AL (2008) Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc Natl Acad Sci USA 105(43):16707\u201316712","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2556_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgg.2012.04.006","volume":"39","author":"RL Carter","year":"2012","unstructured":"Carter RL, Chan AW (2012) Pluripotent stem cells models for Huntington\u2019s disease: prospects and challenges. J Genet Genomics 39(6):253\u2013259","journal-title":"J Genet Genomics"},{"issue":"5","key":"2556_CR38","first-page":"477","volume":"9","author":"B Kisby","year":"2019","unstructured":"Kisby B, Jarrell JT, Agar ME, Cohen DS, Rosin ER, Cahill CM, Rogers JT, Huang X (2019) Alzheimer\u2019s disease and its potential alternative therapeutics. J Alzheimer\u2019s Dis Parkinsonism 9(5):477","journal-title":"J Alzheimer\u2019s Dis Parkinsonism"},{"issue":"7","key":"2556_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/nan.12337","volume":"42","author":"CV Dennis","year":"2016","unstructured":"Dennis CV, Suh LS, Rodriguez ML, Kril JJ, Sutherland GT (2016) Human adult neurogenesis across the ages: an immunohistochemical study. Neuropathol Appl Neurobiol 42(7):621\u2013638","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"2556_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13287-015-0248-1","volume":"14","author":"I Kerkis","year":"2015","unstructured":"Kerkis I, Haddad MS, Valverde CW, Glosman S (2015) Neural and mesenchymal stem cells in animal models of Huntington\u2019s disease: past experiences and future challenges. Stem Cell Res Ther 14(6):232","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"2556_CR41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s13311-019-00810-8","volume":"16","author":"S Naphade","year":"2019","unstructured":"Naphade S, Tshilenge KT, Ellerby LM (2019) Modeling polyglutamine expansion diseases with induced pluripotent stem cells. Neurotherapeutics 16(4):979\u2013998","journal-title":"Neurotherapeutics"},{"issue":"2","key":"2556_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM (2012) Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11(2):253\u201363","journal-title":"Cell Stem Cell"},{"key":"2556_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-7825-0_4","volume":"1780","author":"C Geater","year":"2018","unstructured":"Geater C, Hernandez S, Thompson L, Mattis VB (2018) Cellular models: HD patient-derived pluripotent stem cells. Methods Mol Biol 1780:41\u201373","journal-title":"Methods Mol Biol"},{"issue":"2017","key":"2556_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2015.10.001","volume":"1656","author":"VB Mattis","year":"2017","unstructured":"Mattis VB, Svendsen SN (2017) Modeling Huntington\u2019s disease with patient-derived neurons. Brain Res 1656(2017):76\u201387","journal-title":"Brain Res"},{"key":"2556_CR45","doi-asserted-by":"publisher","first-page":"16880","DOI":"10.1038\/s41598-017-17275-4","volume":"7","author":"E Singer","year":"2017","unstructured":"Singer E, Walter C, Weber JJ, Krahl A, Mau-Holzmann UA, Rischert N, Riess O, Clemensson LE et al. (2017) Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease. Sci Rep 7:16880","journal-title":"Sci Rep"},{"issue":"19","key":"2556_CR46","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst C, Vrbanac V, Weaver M, Li X, Li S, Yi H et al. (2000) Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum Mol Genet 9(19):2799\u20132809","journal-title":"Hum Mol Genet"},{"issue":"19","key":"2556_CR47","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum Mol Genet 9(19):2799\u20132809","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2556_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00418-007-0272-z","volume":"127","author":"J Wanderer","year":"2007","unstructured":"Wanderer J, Morton AJ (2007) Differential morphology and composition of inclusions in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease. Histochem Cell Biol 127(5):473\u2013484","journal-title":"Histochem Cell Biol"},{"issue":"6","key":"2556_CR49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/hmg\/ddl017","volume":"15","author":"H Wang","year":"2006","unstructured":"Wang H, Lim PJ, Yin C, Rieckher M, Vogel BE, Monteiro MJ (2006) Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington\u2019s disease by ubiquilin. Hum Mol Genet 15(6):1025\u20131041","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2556_CR50","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, Clementi E, Hackam A et al. (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20(10):3705\u20133713","journal-title":"J Neurosci"},{"issue":"18","key":"2556_CR51","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease. Proc Natl Acad Sci USA 100(18):10483\u201310487","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2556_CR52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/cells8090962","volume":"8","author":"G Chaves","year":"2019","unstructured":"Chaves G, Stanley J, Pourmand N (2019) Mutant huntingtin affects diabetes and Alzheimer\u2019s markers in human and cell models of Huntington\u2019s disease. Cells 8(9):962","journal-title":"Cells"},{"issue":"4","key":"2556_CR53","doi-asserted-by":"publisher","first-page":"e2206","DOI":"10.1038\/cddis.2016.104","volume":"7","author":"F L\u2019Episcopo","year":"2016","unstructured":"L\u2019Episcopo F, Drouin-Ouellet J, Tirolo C, Pulvirenti A, Giugno R, Testa N, Caniglia S, Serapide MF et al. (2016) GSK-3\u03b2-induced Tau pathology drives hippocampal neuronal cell death in Huntington\u2019s disease: involvement of astrocyte-neuron interactions. Cell Death Dis 7(4):e2206","journal-title":"Cell Death Dis"},{"issue":"4","key":"2556_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G, Cattaneo E (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ 22(4):690\u2013702","journal-title":"Cell Death Differ"},{"issue":"9","key":"2556_CR55","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","volume":"22","author":"H Hsiao","year":"2013","unstructured":"Hsiao H, Chen Y, Chen H, Tu P, Chern Y (2013) A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington\u2019s disease. Hum Mol Genet 22(9):1826\u20131842","journal-title":"Hum Mol Genet"},{"issue":"52","key":"2556_CR56","doi-asserted-by":"publisher","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 106(52):22480\u201322485","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2556_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jnr.22184","volume":"88","author":"A Valencia","year":"2010","unstructured":"Valencia A, Reeves PB, Sapp E, Li X, Alexander J, Kegel KB, Chase K, Aronin N et al. (2010) Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington\u2019s disease. J Neurosci Res 88(1):179\u2013190","journal-title":"J Neurosci Res"},{"issue":"34","key":"2556_CR58","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0361-9230(01)00598-6","volume":"56","author":"Q Chu-LaGraff","year":"2001","unstructured":"Chu-LaGraff Q, Kang X, Messer A (2001) Expression of the Huntington\u2019s disease transgene in neural stem cell cultures from R6\/2 transgenic mice. Brain Res Bull 56(34):307\u2013312","journal-title":"Brain Res Bull"},{"issue":"50","key":"2556_CR59","doi-asserted-by":"publisher","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","volume":"25","author":"W Phillips","year":"2005","unstructured":"Phillips W, Morton AJ, Barker AR (2005) Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington\u2019s disease are attributable to the in vivo microenvironment. J Neurosci 25(50):11564\u201311576","journal-title":"J Neurosci"},{"issue":"1","key":"2556_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","volume":"23","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Chesselet MF (2002) Mouse models of Huntington\u2019s disease. Trends Pharmacol Sci 23(1):32\u201339","journal-title":"Trends Pharmacol Sci"},{"issue":"34","key":"2556_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1242\/dmm.002451","volume":"2","author":"DE Ehrnhoefer","year":"2009","unstructured":"Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR (2009) Mouse models of Huntington disease: variations on a theme. Dis Model Mech 2(34):123\u2013129","journal-title":"Dis Model Mech"},{"issue":"1","key":"2556_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 465(1):11\u201326","journal-title":"J Comp Neurol"},{"issue":"5222","key":"2556_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella GF, Joyner AL (1995) Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269(5222):407\u2013410","journal-title":"Science"},{"issue":"5","key":"2556_CR64","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD et al. (1995) Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81(5):811\u2013823","journal-title":"Cell"},{"issue":"2","key":"2556_CR65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat Genet 11(2):155\u2013163","journal-title":"Nat Genet"},{"issue":"3","key":"2556_CR66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","volume":"2","author":"LB Menalled","year":"2005","unstructured":"Menalled LB (2005) Knock-in mouse models of Huntington\u2019s disease. NeuroRx. 2(3):465\u2013470","journal-title":"NeuroRx."},{"issue":"1","key":"2556_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101(1):57\u201366","journal-title":"Cell"},{"issue":"3","key":"2556_CR68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","volume":"69","author":"ZR Crook","year":"2011","unstructured":"Crook ZR, Housman D (2011) Huntington\u2019s disease: can mice lead the way to treatment? Neuron 69(3):423\u2013435","journal-title":"Neuron"},{"issue":"11","key":"2556_CR69","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","volume":"27","author":"MS Levine","year":"2004","unstructured":"Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF (2004) Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect. Trends Neurosci 27(11):691\u2013697","journal-title":"Trends Neurosci"},{"issue":"1","key":"2556_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/hmg\/ddu421","volume":"24","author":"D Blum","year":"2015","unstructured":"Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N et al. (2015) Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Hum Mol Genet 24(1):76\u201385","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2556_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/hmg\/ddu456","volume":"24","author":"M Gratuze","year":"2015","unstructured":"Gratuze M, No\u00ebl A, Julien C, Cisbani G, Milot-Rousseau P, Morin F, Dickler M, Goupil C et al. (2015) Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington\u2019s disease. Hum Mol Genet 24(1):86\u201399","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2556_CR72","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.nbd.2010.10.023","volume":"41","author":"F L\u2019Episcopo","year":"2011","unstructured":"L\u2019Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Cossetti C, D\u2019Adamo P, Zardini E et al. (2011) Reactive astrocytes and Wnt\/\u03b2-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. Neurobiol Dis 41(2):508\u2013527","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2556_CR73","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1113\/jphysiol.2012.241018","volume":"591","author":"A Dvorzhak","year":"2013","unstructured":"Dvorzhak A, Semtner M, Faber DS, Grantyn R (2013) Tonic mGluR5\/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin. J Physiol 591(4):1145\u20131166","journal-title":"J Physiol"},{"issue":"4","key":"2556_CR74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein DC (2002) Lessons from animal models of Huntington\u2019s disease. Trends Genet 18(4):202\u2013209","journal-title":"Trends Genet"},{"issue":"2","key":"2556_CR75","doi-asserted-by":"publisher","first-page":"e00033","DOI":"10.1042\/AN20090058","volume":"2","author":"C Cepeda","year":"2010","unstructured":"Cepeda C, Cummings DM, Andr\u00e9 VM, Holley SM, Levine MS (2010) Genetic mouse models of Huntington\u2019s disease: focus on electrophysiological mechanisms. ASN Neuro. 2(2):e00033","journal-title":"ASN Neuro."},{"key":"2556_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/7854_2013_246","volume":"22","author":"XJ Li","year":"2015","unstructured":"Li XJ, Li S (2015) Large animal models of Huntington\u2019s disease. Curr Top Behav Neurosci 22:149\u2013160","journal-title":"Curr Top Behav Neurosci"},{"issue":"4","key":"2556_CR77","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cell.2018.03.005","volume":"173","author":"S Yan","year":"2018","unstructured":"Yan S, Tu Z, Liu Z, Fan N, Yang H, Yang S, Yang W, Zhao Y, Ouyang Z et al. (2018) A Huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington\u2019s disease. Cell 173(4):989\u20131002","journal-title":"Cell"},{"issue":"1","key":"2556_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cr.2019.01.001","volume":"8","author":"S Yan","year":"2019","unstructured":"Yan S, Li S, Li XJ (2019) Use of large animal models to investigate Huntington\u2019s diseases. Cell Regen 8(1):9\u201311","journal-title":"Cell Regen"},{"issue":"3","key":"2556_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JHD-200425","volume":"9","author":"D Howland","year":"2020","unstructured":"Howland D, Ellederova Z, Aronin N, Fernau D, Gallagher J, Taylor Hennebold J, Weiss AR, Gray-Edwards H et al. (2020) Large animal models of Huntington\u2019s disease: what we have learned and where we need to go next. J Huntingtons Dis 9(3):201\u2013216","journal-title":"J Huntingtons Dis"},{"issue":"1\u20132","key":"2556_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainresrev.2010.11.004","volume":"67","author":"PH Reddy","year":"2011","unstructured":"Reddy PH, Reddy TP, Manczak M, Calkins MJ, Shirendeb U, Mao P (2011) Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev 67(1\u20132):103\u2013118","journal-title":"Brain Res Rev"},{"issue":"s1","key":"2556_CR81","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.3233\/JAD-190851","volume":"72","author":"N Sawant","year":"2019","unstructured":"Sawant N, Reddy PH (2019) Role of phosphorylated Tau and glucose synthase kinase 3 beta in Huntington\u2019s disease progression. J Alzheimers Dis 72(s1):S177\u2013S191","journal-title":"J Alzheimers Dis"},{"key":"2556_CR82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mito.2020.08.003","volume":"55","author":"P Pantiya","year":"2020","unstructured":"Pantiya P, Thonusin C, Chattipakorn N, Chattipakorn SC (2020) Mitochondrial abnormalities in neurodegenerative models and possible interventions: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease. Mitochondrion 55:14\u201347","journal-title":"Mitochondrion"},{"key":"2556_CR83","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-1-19","volume":"1","author":"S Li","year":"2006","unstructured":"Li S, Li XJ (2006) Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 1:19","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2556_CR84","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5(8):731\u2013736","journal-title":"Nat Neurosci"},{"issue":"7","key":"2556_CR85","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","volume":"19","author":"PH Reddy","year":"2014","unstructured":"Reddy PH (2014) Increased mitochondrial fission and neuronal dysfunction in Huntington\u2019s disease: implications for molecular inhibitors of excessive mitochondrial fission. Drug Discov Today 19(7):951\u2013955","journal-title":"Drug Discov Today"},{"issue":"9","key":"2556_CR86","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/cells8090961","volume":"8","author":"D Oliver","year":"2019","unstructured":"Oliver D, Reddy PH (2019) Dynamics of dynamin-related protein 1 in Alzheimer\u2019s disease and other neurodegenerative diseases. Cells 8(9):961","journal-title":"Cells"},{"issue":"25","key":"2556_CR87","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.1093\/hmg\/ddv429","volume":"24","author":"M Manczak","year":"2015","unstructured":"Manczak M, Reddy PH (2015) Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington\u2019s disease. Hum Mol Genet 24(25):7308\u20137325","journal-title":"Hum Mol Genet"},{"key":"2556_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.12.004","volume":"127","author":"AU Joshi","year":"2019","unstructured":"Joshi AU, Ebert AE, Haileselassie B, Mochly-Rosen D (2019) Drp1\/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington\u2019s disease. J Mol Cell Cardiol 127:125\u2013133","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2556_CR89","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA et al. (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17(3):377\u2013382","journal-title":"Nat Med"},{"issue":"11","key":"2556_CR90","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/ars.2012.4928","volume":"19","author":"F Haun","year":"2013","unstructured":"Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA (2013) S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington\u2019s disease Antioxid. Redox Signal 19(11):1173\u20131184","journal-title":"Redox Signal"},{"issue":"11","key":"2556_CR91","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.7150\/ijbs.20742","volume":"13","author":"ZN Huang","year":"2017","unstructured":"Huang ZN, Chung HM, Fang SC, Her LS (2017) Adhesion regulating molecule 1 mediates HAP40 overexpression-induced mitochondrial defects. Int J Biol Sci 13(11):1420\u20131437","journal-title":"Int J Biol Sci"},{"issue":"9","key":"2556_CR92","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.1007\/s12035-016-0247-y","volume":"54","author":"ZN Huang","year":"2017","unstructured":"Huang ZN, Her LS (2017) The ubiquitin receptor ADRM1 modulates HAP40-induced proteasome activity. Mol Neurobiol 54(9):7382\u20137400","journal-title":"Mol Neurobiol"},{"key":"2556_CR93","doi-asserted-by":"publisher","first-page":"105240","DOI":"10.1016\/j.phrs.2020.105240","volume":"163","author":"X Li","year":"2021","unstructured":"Li X, Huang L, Lan J, Feng X, Li P, Wu L, Peng Y (2021) Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases. Pharmacol Res 163:105240","journal-title":"Pharmacol Res"},{"issue":"14","key":"2556_CR94","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/hmg\/ddy154","volume":"27","author":"PH Reddy","year":"2018","unstructured":"Reddy PH, Yin X, Manczak M, Kumar S, Pradeepkiran JA, Vijayan M, Reddy AP (2018) Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer\u2019s disease. Hum Mol Genet 27(14):2502\u20132516","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2556_CR95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/hmg\/ddy335","volume":"28","author":"M Manczak","year":"2019","unstructured":"Manczak M, Kandimalla R, Yin X, Reddy PH (2019) Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum Mol Genet 28(2):177\u2013199","journal-title":"Hum Mol Genet"},{"issue":"2020","key":"2556_CR96","first-page":"107705","volume":"219","author":"S Jamwal","year":"2020","unstructured":"Jamwal S, Blackburn JK, Elsworth JD (2020) PPAR\u03b3\/PGC1\u03b1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders. Pharmacol Ther 219(2020):107705","journal-title":"Pharmacol Ther"},{"key":"2556_CR97","doi-asserted-by":"publisher","first-page":"108698","DOI":"10.1016\/j.abb.2020.108698","volume":"702","author":"J Johnson","year":"2020","unstructured":"Johnson J, Mercado-Ayon E, Mercado-Ayon Y, Dong YN, Halawani S, Ngaba L, Lynch DR (2020) Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys 702:108698","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"2556_CR98","first-page":"617","volume":"9","author":"TC Kang","year":"2020","unstructured":"Kang TC (2020) Nuclear factor-erythroid 2-related factor 2 (Nrf2) and mitochondrial dynamics\/mitophagy in neurological diseases. Antioxidants (Basel, Switzerland) 9(7):617","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"7","key":"2556_CR99","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","volume":"53","author":"A Siddiqui","year":"2012","unstructured":"Siddiqui A, Rivera-S\u00e1nchez S, Castro Mdel R, Acevedo-Torres K, Rane A, Torres-Ramos CA, Nicholls DG, Andersen JK et al. (2012) Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington\u2019s disease. Free Radic Biol Med 53(7):1478\u20131488","journal-title":"Free Radic Biol Med"},{"issue":"7694","key":"2556_CR100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature25502","volume":"555","author":"Q Guo","year":"2018","unstructured":"Guo Q, Huang B, Cheng J, Seefelder M, Engler T, Pfeifer G, Oeckl P, Otto M, Moser F et al. (2018) The cryo-electron microscopy structure of huntingtin. Nature 555(7694):117\u2013120","journal-title":"Nature"},{"issue":"10","key":"2556_CR101","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.4161\/cc.20423","volume":"11","author":"T Ratovitski","year":"2012","unstructured":"Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN, Ross CA (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle. 11(10):2006\u20132021","journal-title":"Cell Cycle."},{"issue":"3","key":"2556_CR102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1044-7431(02)00013-1","volume":"22","author":"VV Senatorov","year":"2003","unstructured":"Senatorov VV, Charles V, Reddy PH, Tagle DA, Chuang DM (2003) Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington\u2019s disease. Mol Cell Neurosci 22(3):285\u2013297","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"2556_CR103","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20(3):146\u2013154","journal-title":"Trends Genet"},{"issue":"4","key":"2556_CR104","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/hmg\/ddl467","volume":"16","author":"ANT Strehlow","year":"2007","unstructured":"Strehlow ANT, Li JZ, Myers RM (2007) Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum Mol Genet 16(4):391\u2013409","journal-title":"Hum Mol Genet"},{"issue":"21","key":"2556_CR105","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","volume":"16","author":"RS Atwal","year":"2007","unstructured":"Atwal RS, Xia J, Pinchev D, Taylor J, Epand RM, Truant R (2007) Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet 16(21):2600\u20132615","journal-title":"Hum Mol Genet"},{"issue":"20","key":"2556_CR106","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","volume":"14","author":"CL Benn","year":"2005","unstructured":"Benn CL, Landles C, Li H, Strand AD, Woodman B, Sathasivam K, Li SH, Ghazi-Noori S et al. (2005) Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington\u2019s disease. Hum Mol Genet 14(20):3065\u20133078","journal-title":"Hum Mol Genet"},{"issue":"5334","key":"2556_CR107","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990\u20131993","journal-title":"Science"},{"issue":"3","key":"2556_CR108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537\u2013548","journal-title":"Cell"},{"issue":"3","key":"2556_CR109","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","volume":"19","author":"M Kim","year":"1999","unstructured":"Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, Kim TW, Williams M et al. (1999) Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 19(3):964\u2013973","journal-title":"J Neurosci"},{"key":"2556_CR110","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.conb.2020.04.001","volume":"63","author":"H Vitet","year":"2020","unstructured":"Vitet H, Brandt V, Saudou F (2020) Traffic signaling: new functions of huntingtin and axonal transport in neurological disease. Curr Opin Neurobiol 63:122\u2013130","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"2556_CR111","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1083\/jcb.200509091","volume":"172","author":"A Pal","year":"2006","unstructured":"Pal A, Severin F, Lommer B, Shevchenko A, Zerial M (2006) Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington\u2019s disease. J Cell Biol 172(4):605\u2013618","journal-title":"J Cell Biol"},{"issue":"1","key":"2556_CR112","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4161\/cam.3.1.7511","volume":"3","author":"LL Wu","year":"2009","unstructured":"Wu LL, Zhou XF (2009) Huntingtin associated protein 1 and its functions. Cell Adh Migr 3(1):71\u201376","journal-title":"Cell Adh Migr"},{"issue":"47","key":"2556_CR113","doi-asserted-by":"publisher","first-page":"32870","DOI":"10.1074\/jbc.M802863200","volume":"283","author":"JD Wilbur","year":"2008","unstructured":"Wilbur JD, Chen CY, Manalo V, Hwang PK, Fletterick RJ, Brodsky FM (2008) Actin binding by Hip1 (huntingtin-interacting protein 1) and Hip1R (Hip1-related protein) is regulated by clathrin light chain. J Biol Chem 283(47):32870\u201332879","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"2556_CR114","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","volume":"81","author":"MM Fan","year":"2007","unstructured":"Fan MM, Raymond LA (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease. Prog Neurobiol 81(5\u20136):272\u2013293","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2556_CR115","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.stemcr.2014.02.011","volume":"2","author":"S Elias","year":"2014","unstructured":"Elias S, Thion MS, Yu H, Sousa CM, Lasgi C, Morin X, Humbert S (2014) Huntingtin regulates mammary stem cell division and differentiation. Stem Cell Reports 2(4):491\u2013506","journal-title":"Stem Cell Reports"},{"issue":"3","key":"2556_CR116","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin JD, Colombo K, Molina-Calavita M, Keryer G, Charrin BC, Dietrich P, Volvert ML, Guillemot F et al. (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67(3):392\u2013406","journal-title":"Neuron"},{"issue":"1","key":"2556_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4161\/auto.5201","volume":"4","author":"RS Atwal","year":"2008","unstructured":"Atwal RS, Truant R (2008) A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy. Autophagy 4(1):91\u201393","journal-title":"Autophagy"},{"key":"2556_CR118","doi-asserted-by":"publisher","first-page":"104741","DOI":"10.1016\/j.nbd.2020.104741","volume":"136","author":"M Cherubini","year":"2020","unstructured":"Cherubini M, Lopez-Molina L, Gines S (2020) Mitochondrial fission in Huntington\u2019s disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and reactive oxygen species (ROS) homeostasis. Neurobiol Dis 136:104741","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2556_CR119","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","volume":"51","author":"LM Valor","year":"2015","unstructured":"Valor LM (2015) Transcription, epigenetics and ameliorative strategies in Huntington\u2019s Disease: a genome-wide perspective. Mol Neurobiol 51(1):406\u2013423","journal-title":"Mol Neurobiol"},{"key":"2556_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","volume":"63","author":"RK Chaturvedi","year":"2013","unstructured":"Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1\u201329","journal-title":"Free Radic Biol Med"},{"issue":"32","key":"2556_CR121","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1074\/jbc.271.32.19385","volume":"271","author":"MA Kalchman","year":"1996","unstructured":"Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD et al. (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem 271(32):19385\u201319394","journal-title":"J Biol Chem"},{"issue":"6","key":"2556_CR122","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0166-2236(99)01415-0","volume":"22","author":"PH Reddy","year":"1999","unstructured":"Reddy PH, Williams M, Tagle DA (1999) Recent advances in understanding the pathogenesis of Huntington\u2019s disease. Trends Neurosci 22(6):248\u2013255","journal-title":"Trends Neurosci"},{"issue":"3","key":"2556_CR123","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/biof.1013","volume":"38","author":"MA Sorolla","year":"2012","unstructured":"Sorolla MA, Rodr\u00edguez-Colman MJ, Vall-llaura N, Tamarit J, Ros J, Cabiscol E (2012) Protein oxidation in Huntington disease. Biofactors 38(3):173\u2013185","journal-title":"Biofactors"},{"issue":"20","key":"2556_CR124","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","volume":"96","author":"A Kazantsev","year":"1999","unstructured":"Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci USA 96(20):11404\u201311409","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2556_CR125","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP et al. (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97(12):6763\u20136768","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2556_CR126","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH et al. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47(1):29\u201341","journal-title":"Neuron"},{"issue":"2","key":"2556_CR127","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12031-011-9516-4","volume":"45","author":"JL Illuzzi","year":"2011","unstructured":"Illuzzi JL, Vickers CA, Kmiec EB (2011) Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin. J Mol Neurosci 45(2):256\u2013268","journal-title":"J Mol Neurosci"},{"issue":"1","key":"2556_CR128","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR et al. (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35(1):76\u201383","journal-title":"Nat Genet"},{"issue":"Pt 6","key":"2556_CR129","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1042\/BST0371270","volume":"37","author":"A Bithell","year":"2009","unstructured":"Bithell A, Johnson R, Buckley NJ (2009) Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington\u2019s disease. Biochem Soc Trans 37(Pt 6):1270\u20131275","journal-title":"Biochem Soc Trans"},{"issue":"42","key":"2556_CR130","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B et al. (2008) Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci 28(42):10720\u201310733","journal-title":"J Neurosci"},{"key":"2556_CR131","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/B978-0-12-385883-2.00010-2","volume":"107","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Diamond MI (2012) Huntington disease and the huntingtin protein. Prog Mol Biol Transl Sci 107:189\u2013214","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2556_CR132","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuropharm.2013.10.025","volume":"80","author":"LM Valor","year":"2014","unstructured":"Valor LM, Guiretti D (2014) What\u2019s wrong with epigenetics in Huntington\u2019s disease? Neuropharmacology 80:103\u2013114","journal-title":"Neuropharmacology"},{"issue":"32","key":"2556_CR133","doi-asserted-by":"publisher","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","volume":"110","author":"M Vashishtha","year":"2013","unstructured":"Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, Song W, Lau A et al. (2013) Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci USA 110(32):E3027\u2013E3036","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"2556_CR134","doi-asserted-by":"publisher","first-page":"19176","DOI":"10.1073\/pnas.0606373103","volume":"103","author":"H Ryu","year":"2006","unstructured":"Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ (2006) ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease. Proc Natl Acad Sci USA 103(50):19176\u201319181","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2556_CR135","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2010","unstructured":"Seong IS, Woda JM, Song JJ, Lloret A, Abeyrathne PD, Woo CJ, Gregory G, Lee JM et al. (2010) Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 19(4):573\u2013583","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2556_CR136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127(1):59\u201369","journal-title":"Cell"},{"issue":"16","key":"2556_CR137","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S, Hennessy T, Calingasan N, Yang L, Starkov A, Kiaei M, Cannella M et al. (2009) Impaired PGC-1alpha function in muscle in Huntington\u2019s disease. Hum Mol Genet 18(16):3048\u20133065","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2556_CR138","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps S, Julien JP (2013) Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci 14(3):161\u2013176","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2556_CR139","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S, Reynolds IL (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22(2):388\u2013400","journal-title":"Neurobiol Dis"},{"issue":"9","key":"2556_CR140","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1134\/S0006297918090043","volume":"83","author":"SN Illarioshkin","year":"2018","unstructured":"Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV (2018) Molecular pathogenesis in Huntington\u2019s disease. Biochemistry (Mosc.) 83(9):1030\u20131039","journal-title":"Biochemistry (Mosc.)"},{"issue":"38","key":"2556_CR141","doi-asserted-by":"publisher","first-page":"E5655","DOI":"10.1073\/pnas.1603020113","volume":"113","author":"X Zhao","year":"2016","unstructured":"Zhao X, Chen XQ, Han E, Hu Y, Paik P, Ding Z, Overman J, Lau AL et al. (2016) TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington\u2019s disease. Proc Natl Acad Sci USA 113(38):E5655\u2013E5664","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"2556_CR142","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/hmg\/ddg218","volume":"12","author":"H Li","year":"2003","unstructured":"Li H, Wyman T, Yu ZX, Li SH, Li XJ (2003) Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum Mol Genet 12(16):2021\u20132030","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2556_CR143","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1042\/BST0380488","volume":"38","author":"JL Rozas","year":"2010","unstructured":"Rozas JL, G\u00f3mez-S\u00e1nchez L, Tom\u00e1s-Zapico C, Lucas JJ, Fern\u00e1ndez-Chac\u00f3n R (2010) Presynaptic dysfunction in Huntington\u2019s disease. Biochem Soc Trans 38(2):488\u2013492","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"2556_CR144","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gin\u00e9s","year":"2006","unstructured":"Gin\u00e9s S, Bosch M, Marco S, Gavald\u00e0 N, D\u00edaz-Hern\u00e1ndez M, Lucas JJ, Canals JM, Alberch J (2006) Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur J Neurosci 23(3):649\u2013658","journal-title":"Eur J Neurosci"},{"issue":"7","key":"2556_CR145","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0166-2236(95)93922-K","volume":"18","author":"MV Chao","year":"1995","unstructured":"Chao MV, Hempstead BL (1995) p75 and Trk: a two-receptor system. Trends Neurosci 18(7):321\u2013326","journal-title":"Trends Neurosci"},{"issue":"15","key":"2556_CR146","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","volume":"33","author":"G Liot","year":"2013","unstructured":"Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F (2013) Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci 33(15):6298\u20136309","journal-title":"J Neurosci"},{"key":"2556_CR147","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","volume":"33","author":"JL Plotkin","year":"2015","unstructured":"Plotkin JL, Surmeier DJ (2015) Corticostriatal synaptic adaptations in Huntington\u2019s disease. Curr Opin Neurobiol 33:53\u201362","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"2556_CR148","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1523\/JNEUROSCI.0244-14.2015","volume":"35","author":"RP Murmu","year":"2015","unstructured":"Murmu RP, Li W, Szepesi Z, Li JY (2015) Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington\u2019s disease. J Neurosci 35(1):287\u2013298","journal-title":"J Neurosci"},{"issue":"1","key":"2556_CR149","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","volume":"83","author":"JL Plotkin","year":"2014","unstructured":"Plotkin JL, Day M, Peterson JD, Xie Z, Kress GJ, Rafalovich I, Kondapalli J, Gertler TS, Flajolet M et al.(2014) Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease. Neuron 83(1):178\u2013188","journal-title":"Neuron"},{"issue":"12","key":"2556_CR150","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/jnr.24495","volume":"97","author":"ET Koch","year":"2019","unstructured":"Koch ET, Raymond LA (2019) Dysfunctional striatal dopamine signaling in Huntington\u2019s disease. J Neurosci Res 97(12):1636\u20131654","journal-title":"J Neurosci Res"},{"issue":"4","key":"2556_CR151","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/cns.12844","volume":"24","author":"A Reiner","year":"2018","unstructured":"Reiner A, Deng YP (2018) Disrupted striatal neuron inputs and outputs in Huntington\u2019s disease. CNS Neurosci Ther 24(4):250\u2013280","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"2556_CR152","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/brain\/103.1.179","volume":"103","author":"EG Spokes","year":"1980","unstructured":"Spokes EG (1980) Neurochemical alterations in Huntington\u2019s chorea: a study of post-mortem brain tissue. Brain 103(1):179\u2013210","journal-title":"Brain"},{"issue":"1","key":"2556_CR153","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","volume":"58","author":"MC Garrett","year":"1992","unstructured":"Garrett MC, Soares-da-Silva P (1992) Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: evidence for an overactive dopaminergic brain transmission. J Neurochem 58(1):101\u2013106","journal-title":"J Neurochem"},{"issue":"27","key":"2556_CR154","doi-asserted-by":"publisher","first-page":"24713","DOI":"10.1074\/jbc.M103501200","volume":"276","author":"Y Sun","year":"2001","unstructured":"Sun Y, Savanenin A, Reddy PH, Liu YF (2001) Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J Biol Chem 276(27):24713\u201324718","journal-title":"J Biol Chem"},{"issue":"1","key":"2556_CR155","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2012.05.013","volume":"48","author":"AJ Milnerwood","year":"2012","unstructured":"Milnerwood AJ, Kaufman AM, Sepers MD, Gladding CM, Zhang L, Wang L, Fan J, Coquinco A et al. (2012) Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington\u2019s disease mice. Neurobiol Dis 48(1):40\u201351","journal-title":"Neurobiol Dis"},{"issue":"4","key":"2556_CR156","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4103\/1673-5374.230270","volume":"13","author":"A Rosas-Arellano","year":"2018","unstructured":"Rosas-Arellano A, Estrada-Mondrag\u00f3n A, Mantellero CA, Tejeda-Guzm\u00e1n C, Castro MA (2018) The adjustment of \u03b3-aminobutyric acid A tonic subunits in Huntington\u2019s disease: from transcription to translation to synaptic levels into the neostriatum. Neural Regen Res 13(4):584\u2013590","journal-title":"Neural Regen Res"},{"key":"2556_CR157","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13670-011-0005-y","volume":"1","author":"EA Wang","year":"2012","unstructured":"Wang EA, Cepeda C, Levine MS (2012) Cognitive deficits in Huntington\u2019s disease: Insights from animal models. Curr Tran Geriatr Gerontol Rep 1:29\u201338","journal-title":"Curr Tran Geriatr Gerontol Rep"},{"issue":"10","key":"2556_CR158","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1073\/pnas.93.10.5037","volume":"93","author":"J Bao","year":"1996","unstructured":"Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 93(10):5037\u20135042","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2556_CR159","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.febslet.2010.02.022","volume":"584","author":"A Rasola","year":"2010","unstructured":"Rasola A, Sciacovelli M, Pantic B, Bernardi P (2010) Signal transduction to the permeability transition pore. FEBS Lett 584(10):1989\u20131996","journal-title":"FEBS Lett"},{"issue":"9","key":"2556_CR160","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 283(9):5780\u20135789","journal-title":"J Biol Chem"},{"key":"2556_CR161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-8-45","volume":"8","author":"RA Quintanilla","year":"2013","unstructured":"Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV (2013) Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol Neurodegener 8:45","journal-title":"Mol Neurodegener"},{"issue":"46","key":"2556_CR162","doi-asserted-by":"publisher","first-page":"34785","DOI":"10.1074\/jbc.M603845200","volume":"281","author":"T Milakovic","year":"2006","unstructured":"Milakovic T, Quintanilla RA, Johnson GV (2006) Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. J Biol Chem 281(46):34785\u201334795","journal-title":"J Biol Chem"},{"issue":"1","key":"2556_CR163","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL, Sullivan PG, Steffan JS et al. (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16(1):61\u201377","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2556_CR164","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0896-6273(03)00366-0","volume":"39","author":"TS Tang","year":"2003","unstructured":"Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, Hayden MR, Bezprozvanny I (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39(2):227\u2013239","journal-title":"Neuron"},{"issue":"4","key":"2556_CR165","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cns.12817","volume":"24","author":"JP Mackay","year":"2018","unstructured":"Mackay JP, Nassrallah WB, Raymond LA (2018) Cause or compensation?-Altered neuronal Ca2+ handling in Huntington\u2019s disease. CNS Neurosci Ther 24(4):301\u2013310","journal-title":"CNS Neurosci Ther"},{"issue":"50","key":"2556_CR166","doi-asserted-by":"publisher","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","volume":"27","author":"HB Fernandes","year":"2007","unstructured":"Fernandes HB, Baimbridge KG, Church J, Hayden MR, Raymond LA (2007) Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington\u2019s disease. J Neurosci 27(50):13614\u201313623","journal-title":"J Neurosci"},{"issue":"43","key":"2556_CR167","doi-asserted-by":"publisher","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","volume":"26","author":"JM Oliveira","year":"2006","unstructured":"Oliveira JM, Chen S, Almeida S, Riley R, Gon\u00e7alves J, Oliveira CR, Hayden MR, Nicholls DG et al. (2006) Mitochondrial-dependent Ca2+ handling in Huntington\u2019s disease striatal cells: effect of histone deacetylase inhibitors. J Neurosci 26(43):11174\u201311186","journal-title":"J Neurosci"},{"issue":"3","key":"2556_CR168","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","volume":"25","author":"MM Zeron","year":"2004","unstructured":"Zeron MM, Fernandes HB, Krebs C, Shehadeh J, Wellington CL, Leavitt BR, Baimbridge KG, Hayden MR et al. (2004) Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington\u2019s disease. Mol Cell Neurosci 25(3):469\u2013479","journal-title":"Mol Cell Neurosci"},{"issue":"14","key":"2556_CR169","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13(14):1407\u20131420","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2556_CR170","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/biof.162","volume":"37","author":"M Giacomello","year":"2011","unstructured":"Giacomello M, Hudec R, Lopreiato R (2011) Huntington\u2019s disease, calcium, and mitochondria. Biofactors 37(3):206\u2013218","journal-title":"Biofactors"},{"issue":"6","key":"2556_CR171","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14(6):383\u2013400","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"2556_CR172","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.33549\/physiolres.932678","volume":"63","author":"V Vyklicky","year":"2014","unstructured":"Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, Lichnerova K, Cerny J et al. (2014) Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 63(Suppl 1):S191\u2013S203","journal-title":"Physiol Res"},{"issue":"2","key":"2556_CR173","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nrd1958","volume":"5","author":"SA Lipton","year":"2006","unstructured":"Lipton SA (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5(2):160\u2013170","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2556_CR174","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","volume":"97","author":"HS Chen","year":"2006","unstructured":"Chen HS, Lipton SA (2006) The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97(6):1611\u20131626","journal-title":"J Neurochem"},{"issue":"6","key":"2556_CR175","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","volume":"33","author":"MM Zeron","year":"2002","unstructured":"Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease. Neuron 33(6):849\u2013860","journal-title":"Neuron"},{"issue":"4","key":"2556_CR176","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.mcn.2011.05.001","volume":"48","author":"CM Gladding","year":"2011","unstructured":"Gladding CM, Raymond LA (2011) Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function. Mol Cell Neurosci 48(4):308\u2013320","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"2556_CR177","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","volume":"82","author":"MP Parsons","year":"2014","unstructured":"Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorder. Neuron 82(2):279\u2013293","journal-title":"Neuron"},{"issue":"5932","key":"2556_CR178","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.1172871","volume":"324","author":"S Subramaniam","year":"2009","unstructured":"Subramaniam S, Sixt KM, Barrow R, Snyder SH (2009) Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324(5932):1327\u20131330","journal-title":"Science"},{"issue":"1633","key":"2556_CR179","doi-asserted-by":"publisher","first-page":"20130163","DOI":"10.1098\/rstb.2013.0163","volume":"369","author":"OA Shipton","year":"2013","unstructured":"Shipton OA, Paulsen O (2013) GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity. Philos Trans R Soc Lond B Biol Sci 369(1633):20130163","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"2556_CR180","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/jnr.1244","volume":"66","author":"C Cepeda","year":"2001","unstructured":"Cepeda C, Ariano MA, Calvert CR, Flores-Hern\u00e1ndez J, Chandler SH, Leavitt BR, Hayden MR, Levine MS (2001) NMDA receptor function in mouse models of Huntington disease. J Neurosci Res 66(4):525\u2013539","journal-title":"J Neurosci Res"},{"issue":"8","key":"2556_CR181","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nm.3246","volume":"19","author":"S Marco","year":"2013","unstructured":"Marco S, Giralt A, Petrovic MM, Pouladi MA, Mart\u00ednez-Turrilla R, Mart\u00ednez-Hern\u00e1ndez J, Kaltenbach LS, Torres-Peraza J et al. (2013) Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington\u2019s disease models. Nat Med 19(8):1030\u20131038","journal-title":"Nat Med"},{"issue":"6","key":"2556_CR182","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.neuron.2004.11.027","volume":"44","author":"K Huang","year":"2004","unstructured":"Huang K, Yanai A, Kang R, Arstikaitis P, Singaraja RR, Metzler M, Mullard A, Haigh B et al. (2004) Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44(6):977\u2013986","journal-title":"Neuron"},{"issue":"12","key":"2556_CR183","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2056","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE, Zaidi R, Clemente A et al. (2009) Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med 15(12):1407\u20131413","journal-title":"Nat Med"},{"issue":"20","key":"2556_CR184","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1523\/JNEUROSCI.6407-11.2012","volume":"32","author":"C Puddifoot","year":"2012","unstructured":"Puddifoot C, Martel MA, Soriano FX, Camacho A, Vidal-Puig A, Wyllie DJ, Hardingham HE (2012) PGC-1\u03b1 negatively regulates extrasynaptic NMDAR activity and excitotoxicity. J Neurosci 32(20):6995\u20137000","journal-title":"J Neurosci"},{"issue":"7","key":"2556_CR185","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"TS Tang","year":"2005","unstructured":"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llin\u00e1s R, Kristal BS, Hayden MR et al. (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease. Proc Natl Acad Sci USA 102(7):2602\u20132607","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2556_CR186","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","volume":"86","author":"GJ Klapstein","year":"2001","unstructured":"Klapstein GJ, Fisher FS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice. J Neurophysiol 86(6):2667\u20132677","journal-title":"J Neurophysiol"},{"issue":"4","key":"2556_CR187","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbrc.2016.07.058","volume":"483","author":"LA Raymond","year":"2017","unstructured":"Raymond LA (2017) Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochem Biophys Res Commun 483(4):1051\u20131062","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2556_CR188","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante FJ, Beal MF (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington\u2019s disease. J Neurochem 79(6):1246\u20131249","journal-title":"J Neurochem"},{"issue":"5","key":"2556_CR189","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41(5):646\u2013653","journal-title":"Ann Neurol"},{"issue":"1","key":"2556_CR190","doi-asserted-by":"publisher","first-page":"9817","DOI":"10.1038\/s41598-018-27985-y","volume":"8","author":"G Askeland","year":"2018","unstructured":"Askeland G, Dosoudilova Z, Rodinova M, Klempir J, Liskova I, Ku\u015bnierczyk A, Bj\u00f8r\u00e5s M, Nesse G et al. (2018) Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington\u2019s disease patients. Sci Rep 8(1):9817","journal-title":"Sci Rep"},{"key":"2556_CR191","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1427.008","volume":"1147","author":"EC Stack","year":"2008","unstructured":"Stack EC, Matson WR, Ferrante RJ (2008) Evidence of oxidant damage in Huntington\u2019s disease: translational strategies using antioxidants. Ann NY Acad Sci 1147:79\u201392","journal-title":"Ann NY Acad Sci"},{"issue":"15","key":"2556_CR192","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1021\/jm200605a","volume":"54","author":"I T\u00fanez","year":"2011","unstructured":"T\u00fanez I, S\u00e1nchez-L\u00f3pez F, Ag\u00fcera E, Fern\u00e1ndez-Bola\u00f1os R, S\u00e1nchez FM, Tasset-Cuevas I (2011) Important role of oxidative stress biomarkers in Huntington\u2019s disease. J Med Chem 54(15):5602\u20135606","journal-title":"J Med Chem"},{"issue":"3","key":"2556_CR193","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.nbd.2012.02.012","volume":"46","author":"JD Long","year":"2012","unstructured":"Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS (2012) PREDICT-HD Investigators and Coordinators of the Huntington Study Group 8OHdG as a marker for Huntington disease progression. Neurobiol Dis 46(3):625\u2013634","journal-title":"Neurobiol Dis"},{"key":"2556_CR194","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.dnarep.2014.03.003","volume":"18","author":"JM Strand","year":"2014","unstructured":"Strand JM, Scheffler K, Bj\u00f8r\u00e5s M, Eide L (2014) The distribution of DNA damage is defined by region-specific susceptibility to DNA damage formation rather than repair differences. DNA Repair (Amst) 18:44\u201351","journal-title":"DNA Repair (Amst)"},{"issue":"2","key":"2556_CR195","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","volume":"66","author":"SM Hersch","year":"2006","unstructured":"Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, Como P, Zimmerman C et al. (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG. Neurology 66(2):250\u2013252","journal-title":"Neurology"},{"key":"2556_CR196","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","volume":"62","author":"S Ayala-Pe\u00f1a","year":"2013","unstructured":"Ayala-Pe\u00f1a S (2013) Role of oxidative DNA damage in mitochondrial dysfunction and Huntington\u2019s disease pathogenesis. Free Radic Biol Med 62:102\u2013110","journal-title":"Free Radic Biol Med"},{"issue":"17","key":"2556_CR197","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1128\/MCB.23.17.6063-6074.2003","volume":"23","author":"C Spiro","year":"2003","unstructured":"Spiro C, McMurray CT (2003) Nuclease-deficient FEN-1 blocks Rad51\/BRCA1-mediated repair and causes trinucleotide repeat instability. Mol Cell Biol 23(17):6063\u20136074","journal-title":"Mol Cell Biol"},{"issue":"7143","key":"2556_CR198","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature05778","volume":"447","author":"IV Kovtun","year":"2007","unstructured":"Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447(7143):447\u2013452","journal-title":"Nature"},{"issue":"12","key":"2556_CR199","doi-asserted-by":"publisher","first-page":"1000749","DOI":"10.1371\/journal.pgen.1000749","volume":"5","author":"AV Goula","year":"2009","unstructured":"Goula AV, Berquist BR, Wilson DM 3rd, Wheeler VC, Trottier Y, Merienne K (2009) Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington\u2019s disease transgenic mice. PLoS Genet 5(12):1000749","journal-title":"PLoS Genet"},{"issue":"4","key":"2556_CR200","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/70598","volume":"23","author":"K Manley","year":"1999","unstructured":"Manley K, Shirley TL, Flaherty L, Messer A (1999) Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat Genet 23(4):471\u2013473","journal-title":"Nat Genet"},{"issue":"4","key":"2556_CR201","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/86906","volume":"27","author":"IV Kovtun","year":"2001","unstructured":"Kovtun IV, McMurray CT (2001) Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 27(4):407\u2013411","journal-title":"Nat Genet"},{"issue":"1","key":"2556_CR202","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","volume":"33","author":"E Dragileva","year":"2009","unstructured":"Dragileva E, Hendricks A, Teed A, Gillis T, Lopez ET, Friedberg EC, Kucherlapati R, Edelmann W et al. (2009) Intergenerational and striatal CAG repeat instability in Huntington\u2019s disease knock-in mice involve different DNA repair genes. Neurobiol Dis 33(1):37\u201347","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2556_CR203","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1083\/jcb.200905138","volume":"189","author":"Y Enokido","year":"2010","unstructured":"Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H, Sone M, Foulle R et al. (2010) Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol 189(3):425\u2013443","journal-title":"J Cell Biol"},{"issue":"1","key":"2556_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dna.2018.4476","volume":"38","author":"T Maiuri","year":"2019","unstructured":"Maiuri T, Bowie LE, Truant R (2019) DNA repair signaling of Huntingtin: the next link between late-onset neurodegenerative disease and oxidative DNA damage. DNA Cell Biol 38(1):1\u20136","journal-title":"DNA Cell Biol"},{"issue":"2","key":"2556_CR205","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0005-2728(98)00162-5","volume":"1410","author":"JA Morgan-Hughes","year":"1999","unstructured":"Morgan-Hughes JA, Hanna MG (1999) Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochim Biophys Acta 1410(2):125\u2013145","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2556_CR206","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","volume":"145","author":"E Trushina","year":"2007","unstructured":"Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145(4):1233\u20131248","journal-title":"Neuroscience"},{"key":"2556_CR207","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","volume":"893","author":"T Gr\u00fcnewald","year":"1999","unstructured":"Gr\u00fcnewald T, Beal MF (1999) Bioenergetics in Huntington\u2019s disease. Ann NY Acad Sci 893:203\u2013213","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"2556_CR208","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10571-007-9206-5","volume":"27","author":"MM Banoei","year":"2007","unstructured":"Banoei MM, Houshmand M, Panahi MS, Shariati P, Rostami M, Manshadi MD, Majidizadeh T (2007) Huntington\u2019s disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?! Cell Mol Neurobiol 27(7):867\u2013875","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"2556_CR209","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/WNL.45.10.1879","volume":"45","author":"TM Horton","year":"1995","unstructured":"Horton TM, Graham BH, Corral-Debrinski M, Shoffner JM, Kaufman AE, Beal MF, Wallace DC (1995) Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington\u2019s disease patients. Neurology 45(10):1879\u20131883","journal-title":"Neurology"},{"issue":"7","key":"2556_CR210","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.dnarep.2008.03.012","volume":"7","author":"JL Yang","year":"2008","unstructured":"Yang JL, Weissman L, Bohr VA, Mattson MP (2008) Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair (Amst) 7(7):1110\u20131120","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"2556_CR211","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","volume":"272","author":"MC Polidori","year":"1999","unstructured":"Polidori MC, Mecocci P, Browne SE, Senin U, Beal MF (1999) Oxidative damage to mitochondrial DNA in Huntington\u2019s disease parietal cortex. Neurosci Lett 272(1):53\u201356","journal-title":"Neurosci Lett"},{"key":"2556_CR212","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","volume":"11","author":"P Vercruysse","year":"2018","unstructured":"Vercruysse P, Vieau D, Blum D, Peters\u00e9n A, Dupuis L (2018) Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front Mol Neurosci 11:2","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"2556_CR213","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pneurobio.2011.10.004","volume":"97","author":"T Tsunemi","year":"2012","unstructured":"Tsunemi T, La Spada AR (2012) PGC-1\u03b1 at the intersection of bioenergetics regulation and neuron function: from Huntington\u2019s disease to Parkinson\u2019s disease and beyond. Prog Neurobiol 97(2):142\u2013151","journal-title":"Prog Neurobiol"},{"issue":"3","key":"2556_CR214","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ana.25007","volume":"82","author":"JMM van der Burg","year":"2017","unstructured":"van der Burg JMM, Gardiner SL, Ludolph AC, Landwehrmeyer GB, Roos RAC, Aziz NA (2017) Body weight is a robust predictor of clinical progression in Huntington disease. Ann Neurol 82(3):479\u2013483","journal-title":"Ann Neurol"},{"key":"2556_CR215","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.parkreldis.2019.02.004","volume":"63","author":"HP M\u00fcller","year":"2019","unstructured":"M\u00fcller HP, Huppertz HJ, Dreyhaupt J, Ludolph AC, Tabrizi SJ, Roos RAC, Durr A, Landwehrmeyer GB et al. (2019) Combined cerebral atrophy score in Huntington\u2019s disease based on atlas-based MRI volumetry: sample size calculations for clinical trials. Parkinsonism Relat Disord 63:179\u2013184","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"2556_CR216","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1073\/pnas.0609833104","volume":"104","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS (2007) Selective defect of in vivo glycolysis in early Huntington\u2019s disease striatum. Proc Natl Acad Sci USA 104(8):2945\u20132949","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2556_CR217","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/mds.25992","volume":"29","author":"W Duan","year":"2014","unstructured":"Duan W, Jiang M, Jin J (2014) Metabolism in HD: still a relevant mechanism? Mov Disord 29(11):1366\u20131374","journal-title":"Mov Disord"},{"issue":"6","key":"2556_CR218","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00415-015-7753-0","volume":"262","author":"SD S\u00fcssmuth","year":"2015","unstructured":"S\u00fcssmuth SD, M\u00fcller VM, Geitner C, Landwehrmeyer GB, Iff S, Gemperli A, Orth M (2015) Fat-free mass and its predictors in Huntington\u2019s disease. J Neurol 262(6):1533\u201340","journal-title":"J Neurol"},{"issue":"4","key":"2556_CR219","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/eje.0.1510451","volume":"151","author":"V Popovic","year":"2004","unstructured":"Popovic V, Svetel M, Djurovic M, Petrovic S, Doknic M, Pekic S, Miljic D, Milic N et al. (2004) Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease. Eur J Endocrinol 151(4):451\u2013455","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2556_CR220","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archneur.65.4.476","volume":"65","author":"NM Lali\u0107","year":"2008","unstructured":"Lali\u0107 NM, Mari\u0107 J, Svetel M, Joti\u0107 A, Stefanova E, Lali\u0107 K, Dragasevi\u0107 N, Milici\u0107 T et al. (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 65(4):476\u2013480","journal-title":"Arch Neurol"},{"issue":"8","key":"2556_CR221","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","volume":"38","author":"J Labbadia","year":"2013","unstructured":"Labbadia J, Morimoto RI (2013) Huntington\u2019s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38(8):378\u2013385","journal-title":"Trends Biochem Sci"},{"issue":"19","key":"2556_CR222","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM at al. (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14(19):2871\u20132880","journal-title":"Hum Mol Genet"},{"issue":"20","key":"2556_CR223","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/hmg\/ddl248","volume":"15","author":"A Solans","year":"2006","unstructured":"Solans A, Zambrano A, Rodr\u00edguez M, Barrientos A (2006) Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. Hum Mol Genet 15(20):3063\u20133081","journal-title":"Hum Mol Genet"},{"key":"2556_CR224","first-page":"52","volume":"1","author":"M Damiano","year":"1802","unstructured":"Damiano M, Galvan L, D\u00e9glon N (1802) Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1:52\u201361","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2556_CR225","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ydbio.2014.04.005","volume":"391","author":"I Ismailoglu","year":"2014","unstructured":"Ismailoglu I, Chen Q, Popowski M, Yang L, Gross SS, Brivanlou AH (2014) Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells. Dev Biol 391(2):230\u2013240","journal-title":"Dev Biol"},{"key":"2556_CR226","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2018.00342","volume":"12","author":"S Franco-Iborra","year":"2018","unstructured":"Franco-Iborra S, Vila M, Perier C (2018) Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease. Front Neurosci 12:342","journal-title":"Front Neurosci"},{"issue":"4","key":"2556_CR227","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1010911417383","volume":"26","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, P\u00e9rez-Severiano F, Rodr\u00edguez-Mart\u00ednez E, Maldonado PD, Pedraza Chaverri J, R\u00edos C, Segovia J (2001) Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington\u2019s disease. Neurochem Res 26(4):419\u2013424","journal-title":"Neurochem Res"},{"key":"2556_CR228","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnmol.2019.00068","volume":"12","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Impaired redox signaling in Huntington\u2019s disease: therapeutic implications. Front Mol Neurosci 12:68","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"2556_CR229","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bph.14446","volume":"176","author":"JI Sbodio","year":"2019","unstructured":"Sbodio JI, Snyder SH, Paul BD (2019) Regulators of the transsulfuration pathway. Br J Pharmacol 176(4):583\u2013593","journal-title":"Br J Pharmacol"},{"key":"2556_CR230","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/ncomms3917","volume":"4","author":"AI Acu\u00f1a","year":"2013","unstructured":"Acu\u00f1a AI, Esparza M, Kramm C, Beltr\u00e1n FA, Parra AV, Cepeda C, Toro CA, Vidal RL et al. (2013) A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington\u2019s disease in mice. Nat Commun 4:2917","journal-title":"Nat Commun"},{"key":"2556_CR231","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.redox.2015.02.002","volume":"4","author":"KL Berggren","year":"2015","unstructured":"Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, Vargas L, Lothian A et al. (2015) Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6\/2 mouse model of Huntington\u2019s disease. Redox Biol 4:363\u2013374","journal-title":"Redox Biol"},{"issue":"3","key":"2556_CR232","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1080\/15548627.2020.1728096","volume":"17","author":"S Franco-Iborra","year":"2021","unstructured":"Franco-Iborra S, Plaza-Zabala A, Montpeyo M, Sebastian D, Vila M, Martinez-Vicente M (2021) Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. Autophagy 17(3):672\u2013689","journal-title":"Autophagy"},{"issue":"5","key":"2556_CR233","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4103\/1673-5374.249218","volume":"14","author":"U Shefa","year":"2019","unstructured":"Shefa U, Jeong NY, Song IO, Chung HJ, Kim D, Jung J, Huh Y (2019) Mitophagy links oxidative stress conditions and neurodegenerative diseases. Neural Regen Res 14(5):749\u2013756","journal-title":"Neural Regen Res"},{"issue":"1","key":"2556_CR234","doi-asserted-by":"publisher","first-page":"e1617","DOI":"10.1038\/cddis.2014.581","volume":"6","author":"B Khalil","year":"2015","unstructured":"Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Li\u00e9vens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington\u2019s disease. Cell Death Dis. 6(1):e1617","journal-title":"Cell Death Dis."},{"issue":"12","key":"2556_CR235","doi-asserted-by":"publisher","first-page":"e83050","DOI":"10.1371\/journal.pone.0083050","volume":"8","author":"B Baldo","year":"2013","unstructured":"Baldo B, Soylu R, Peters\u00e9n A (2013) Maintenance of basal levels of autophagy in Huntington\u2019s disease mouse models displaying metabolic dysfunction. PloS One 8(12):e83050","journal-title":"PloS One"},{"key":"2556_CR236","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuint.2017.08.004","volume":"117","author":"C Rodolfo","year":"2018","unstructured":"Rodolfo C, Campello S, Cecconi F (2018) Mitophagy in neurodegenerative diseases. Neurochem Int 117:156\u2013166","journal-title":"Neurochem Int"},{"issue":"4","key":"2556_CR237","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","volume":"34","author":"YC Wong","year":"2014","unstructured":"Wong YC, Holzbaur EL (2014) The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci 34(4):1293\u20131305","journal-title":"J Neurosci"},{"issue":"5","key":"2556_CR238","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nn.2528","volume":"13","author":"M Martinez-Vicente","year":"2010","unstructured":"Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, de Vries R, Arias E et al. (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington\u2019s disease. Nat Neurosci 13(5):567\u2013576","journal-title":"Nat Neurosci"},{"issue":"1","key":"2556_CR239","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"P Quinn","year":"2020","unstructured":"Quinn P, Moreira PI, Ambr\u00f3sio AF, Alves CH (2020) PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun 8(1):189","journal-title":"Acta Neuropathol Commun"},{"key":"2556_CR240","first-page":"2484","volume":"11","author":"P Guedes-Dias","year":"1852","unstructured":"Guedes-Dias P, de Proen\u00e7a J, Soares TR, Leit\u00e3o-Rocha A, Pinho BR, Duchen MR (1852) Oliveira JM (2015) HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons. Biochim Biophys Acta 11:2484\u20132493","journal-title":"Biochim Biophys Acta"},{"key":"2556_CR241","first-page":"1345","volume":"8","author":"P Guedes-Dias","year":"1832","unstructured":"Guedes-Dias P (1832) Oliveira JM (2013) Lysine deacetylases and mitochondrial dynamics in neurodegeneration. Biochim Biophys Acta 8:1345\u20131359","journal-title":"Biochim Biophys Acta"},{"key":"2556_CR242","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neulet.2018.03.025","volume":"697","author":"A Stavoe","year":"2019","unstructured":"Stavoe A, Holzbaur E (2019) Axonal autophagy: mini-review for autophagy in the CNS. Neurosci Lett 697:17\u201323","journal-title":"Neurosci Lett"},{"issue":"5","key":"2556_CR243","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15548627.2015.1039219","volume":"11","author":"YN Rui","year":"2015","unstructured":"Rui YN, Xu Z, Patel B, Cuervo AM, Zhang S (2015) HTT\/Huntingtin in selective autophagy and Huntington disease: a foe or a friend within? Autophagy 11(5):858\u2013860","journal-title":"Autophagy"},{"issue":"11","key":"2556_CR244","doi-asserted-by":"publisher","first-page":"26797","DOI":"10.3390\/ijms161125990","volume":"16","author":"Y Kiriyama","year":"2015","unstructured":"Kiriyama Y, Nochi H (2015) The function of autophagy in neurodegenerative diseases. Int J Mol Sci 16(11):26797\u201326812","journal-title":"Int J Mol Sci"},{"key":"2556_CR245","doi-asserted-by":"publisher","first-page":"105433","DOI":"10.1016\/j.phrs.2021.105433","volume":"165","author":"XL Wang","year":"2021","unstructured":"Wang XL, Feng ST, Wang ZZ, Chen NH, Zhang Y (2021) Role of mitophagy in mitochondrial quality control: mechanisms and potential implications for neurodegenerative diseases. Pharmacol Res 165:105433","journal-title":"Pharmacol Res"},{"key":"2556_CR246","doi-asserted-by":"publisher","first-page":"12646","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, Chakrapani S, Joshi AU et al. (2016) VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat Commun 7:12646","journal-title":"Nat Commun"},{"issue":"10","key":"2556_CR247","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.15252\/emmm.201505256","volume":"7","author":"S Hwang","year":"2015","unstructured":"Hwang S, Disatnik MH, Mochly-Rosen D (2015) Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington\u2019s disease. EMBO Mol Med 7(10):1307\u20131326","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2556_CR248","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","volume":"75","author":"DI Shirasaki","year":"2012","unstructured":"Shirasaki DI, Greiner ER, Al-Ramahi I, Gray M, Boontheung P, Geschwind DH, Botas J, Coppola G et al. (2012) Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75(1):41\u201357","journal-title":"Neuron"},{"key":"2556_CR249","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/ncomms2828","volume":"4","author":"K Fujita","year":"2013","unstructured":"Fujita K, Nakamura Y, Oka T, Ito H, Tamura T, Tagawa K, Sasabe T, Katsuta A et al. (2013) A functional deficiency of TERA\/VCP\/p97 contributes to impaired DNA repair in multiple polyglutamine diseases. Nat Commun 4:1816","journal-title":"Nat Commun"},{"key":"2556_CR250","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mito.2021.01.001","volume":"57","author":"S Mani","year":"2021","unstructured":"Mani S, Swargiary G, Chadha R (2021) Mitophagy impairment in neurodegenerative diseases: pathogenesis and therapeutic interventions. Mitochondrion 57:270\u2013293","journal-title":"Mitochondrion"},{"issue":"142","key":"2556_CR251","doi-asserted-by":"publisher","first-page":"142ra97","DOI":"10.1126\/scitranslmed.3003799","volume":"4","author":"T Tsunemi","year":"2012","unstructured":"Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA et al. (2012) PGC-1\u03b1 rescues Huntington\u2019s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4(142):142ra97","journal-title":"Sci Transl Med"},{"key":"2556_CR252","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Beal MF (2013) PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med 62:37\u201346","journal-title":"Free Radic Biol Med"},{"issue":"37","key":"2556_CR253","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1523\/JNEUROSCI.0109-15.2015","volume":"35","author":"A Siddiqui","year":"2015","unstructured":"Siddiqui A, Bhaumik D, Chinta SJ, Rane A, Rajagopalan S, Lieu CA, Lithgow GJ, Andersen JK (2015) Mitochondrial quality control via the PGC1\u03b1-TFEB signaling pathway is compromised by parkin Q311X mutation but independently restored by rapamycin. J Neurosci 35(37):12833\u201312844","journal-title":"J Neurosci"},{"key":"2556_CR254","doi-asserted-by":"crossref","unstructured":"Metzger S, Walter C, Riess O, Roos RA, Nielsen JE, Craufurd D (2013) REGISTRY Investigators of the European Huntington\u2019s Disease Network, H.P. Nguyen, The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One 8(7):e68951","DOI":"10.1371\/journal.pone.0068951"},{"key":"2556_CR255","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2015.05.011","volume":"82","author":"S Swarnkar","year":"2015","unstructured":"Swarnkar S, Chen Y, Pryor WM, Shahani N, Page DT, Subramaniam S (2015) Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington\u2019s disease. Neurobiol Dis 82:66\u201377","journal-title":"Neurobiol Dis"},{"key":"2556_CR256","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","volume":"117","author":"C Vidoni","year":"2018","unstructured":"Vidoni C, Secomandi E, Castiglioni A, Melone MAB, Isidoro C (2018) Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem Int 117:174\u2013187","journal-title":"Neurochem Int"},{"issue":"4","key":"2556_CR257","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/14737175.2015.1025383","volume":"15","author":"LC Schwab","year":"2015","unstructured":"Schwab LC, Garas SN, Drouin-Ouellet J, Mason SL, Stott SR, Barker RA (2015) Dopamine and Huntington\u2019s disease. Expert Rev Neurother 15(4):445\u2013458","journal-title":"Expert Rev Neurother"},{"issue":"47","key":"2556_CR258","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba J, Lukacsovich T, Csikos G, Zheng S, Margulis J, Salazar L, Mao K, Lau AL et al. (2014) Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci USA 111(47):16889\u201316894","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2556_CR259","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.410420411","volume":"42","author":"E Sapp","year":"1997","unstructured":"Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel AP, Aronin N et al. (1997) Huntingtin localization in brains of normal and Huntington\u2019s disease patients. Ann Neurol 42(4):604\u2013612","journal-title":"Ann Neurol"},{"issue":"19","key":"2556_CR260","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1523\/JNEUROSCI.20-19-07268.2000","volume":"20","author":"KB Kegel","year":"2000","unstructured":"Kegel KB, Kim M, Sapp E, McIntyre C, Casta\u00f1o JG, Aronin N, DiFiglia M (2000) Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci 20(19):7268\u20137278","journal-title":"J Neurosci"},{"issue":"2","key":"2556_CR261","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2007.11.019","volume":"14","author":"A Cassidy-Stone","year":"2008","unstructured":"Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT et al. (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14(2):193\u2013204","journal-title":"Dev Cell"},{"issue":"11","key":"2556_CR262","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnmol.2018.00003","volume":"17","author":"A Ruiz","year":"2018","unstructured":"Ruiz A, Alberdi E, Matute C (2018) Mitochondrial division inhibitor 1 (mdivi-1) protects neurons against excitotoxicity through the modulation of mitochondrial function and intracellular Ca2+ signaling. Front Mol Neurosci 17(11):3","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2556_CR263","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1476-5381.2012.01994.x","volume":"168","author":"ME Solesio","year":"2013","unstructured":"Solesio ME, Saez-Atienzar S, Jordan J, Galindo MF (2013) 3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activating the mitochondrial fission pathway. Br J Pharmacol 168(1):63\u201375","journal-title":"Br J Pharmacol"},{"key":"2556_CR264","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.freeradbiomed.2017.08.003","volume":"112","author":"LF Fan","year":"2017","unstructured":"Fan LF, He PY, Peng YC, Du QH, Ma JY, Jin JX, Xu HZ, Li JR et al.(2017) Mdivi-1 ameliorates early brain injury after subarachnoid hemorrhage via the suppression of inflammation-related blood-brain barrier disruption and endoplasmic reticulum stress-based apoptosis. Free Radic Biol Med 112:336\u2013349","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2556_CR265","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.devcel.2017.02.020","volume":"40","author":"EA Bordt","year":"2017","unstructured":"Bordt EA, Clerc P, Roelofs BA, Saladino AJ, Tretter L, Adam-Vizi V, Cherok E, Khalil A et al. (2017) The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species. Dev Cell 40(6):583\u2013594","journal-title":"Dev Cell"},{"issue":"6","key":"2556_CR266","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10(6):839\u2013850","journal-title":"Dev Cell"},{"issue":"1","key":"2556_CR267","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12640-019-00027-9","volume":"36","author":"Y Chen","year":"2019","unstructured":"Chen Y, Xu S, Wang N, Ma Q, Peng P, Yu Y, Zhang L, Ying Z et al. (2019) Dynasore suppresses mTORC1 activity and induces autophagy to regulate the clearance of protein aggregates in neurodegenerative diseases. Neurotox Res 36(1):108\u2013116","journal-title":"Neurotox Res"},{"issue":"Pt 3","key":"2556_CR268","first-page":"789","volume":"126","author":"X Qi","year":"2013","unstructured":"Qi X, Qvit N, Su YC, Mochly-Rosen D (2013) A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci 126(Pt 3):789\u2013802","journal-title":"J Cell Sci"},{"issue":"12","key":"2556_CR269","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1172\/JCI70911","volume":"123","author":"X Guo","year":"2013","unstructured":"Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X (2013) Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. J Clin Invest 123(12):5371\u20135388","journal-title":"J Clin Invest"},{"issue":"1","key":"2556_CR270","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1038\/tp.2014.131","volume":"5","author":"DJ Wright","year":"2015","unstructured":"Wright DJ, Renoir T, Smith ZM, Frazier AE, Francis PS, Thorburn DR, McGee SL, Hannan AJ et al.(2015) N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6\/1 mouse model of Huntington\u2019s disease. Transl Psychiatry 5(1):e492","journal-title":"Transl Psychiatry"},{"key":"2556_CR271","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3389\/fneur.2019.01315","volume":"10","author":"BD Paul","year":"2019","unstructured":"Paul BD, Snyder SH (2019) Therapeutic applications of cysteamine and cystamine in neurodegenerative and neuropsychiatric diseases. Front Neurol 10:1315","journal-title":"Front Neurol"},{"issue":"7","key":"2556_CR272","doi-asserted-by":"publisher","first-page":"e12699","DOI":"10.1111\/jne.12699","volume":"31","author":"O Rudenko","year":"2019","unstructured":"Rudenko O, Springer C, Skov LJ, Madsen AN, Hasholt L, N\u00f8rrem\u00f8lle A, Holst B (2019) Ghrelin-mediated improvements in the metabolic phenotype in the R6\/2 mouse model of Huntington\u2019s disease. J Neuroendocrinol 31(7):e12699","journal-title":"J Neuroendocrinol"},{"issue":"1\u20132","key":"2556_CR273","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2007.07.016","volume":"264","author":"CS Liu","year":"2008","unstructured":"Liu CS, Cheng WL, Kuo SJ, Li JY, Soong BW, Wei YH (2008) Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases. J Neurol Sci 264(1\u20132):18\u201321","journal-title":"J Neurol Sci"},{"issue":"1","key":"2556_CR274","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2013.02.029","volume":"78","author":"NC Kim","year":"2013","unstructured":"Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A et al. (2013) VCP is essential for mitochondrial quality control by PINK1\/Parkin and this function is impaired by VCP mutations. Neuron 78(1):65\u201380","journal-title":"Neuron"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02556-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02556-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T19:21:53Z","timestamp":1699471313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02556-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":274,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02556-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors agreed to publish the contents","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}}]}}